Pharmanutra Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Roberto Lacorte
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 0.1% |
| Management average tenure | no data |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
Investors Interested In Pharmanutra S.p.A.'s (BIT:PHN) Earnings
Sep 11
Pharmanutra's (BIT:PHN) Shareholders Have More To Worry About Than Only Soft Earnings
Mar 23Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?
Sep 26These 4 Measures Indicate That Pharmanutra (BIT:PHN) Is Using Debt Safely
May 16Pharmanutra (BIT:PHN) Could Easily Take On More Debt
Jan 11Capital Allocation Trends At Pharmanutra (BIT:PHN) Aren't Ideal
Nov 02Pharmanutra (BIT:PHN) Will Be Hoping To Turn Its Returns On Capital Around
Aug 03Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?
May 20Returns On Capital Signal Tricky Times Ahead For Pharmanutra (BIT:PHN)
Apr 19Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmanutra S.p.A.'s BIT:PHN) Stock?
Mar 10Is There More To The Story Than Pharmanutra's (BIT:PHN) Earnings Growth?
Feb 17
Should You Be Adding Pharmanutra (BIT:PHN) To Your Watchlist Today?
Feb 01Is Pharmanutra S.p.A. (BIT:PHN) A Smart Choice For Dividend Investors?
Jan 18Is Pharmanutra (BIT:PHN) A Risky Investment?
Jan 04Shareholders Of Pharmanutra (BIT:PHN) Must Be Happy With Their 220% Total Return
Dec 22Do Insiders Own Lots Of Shares In Pharmanutra S.p.A. (BIT:PHN)?
Dec 08Is Pharmanutra S.p.A.'s(BIT:PHN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 23CEO
Roberto Lacorte (56 yo)
no data
Tenure
€1,918,290
Compensation
Mr. Roberto Lacorte serves as Vice Chairman, Managing Director and Vice President of Pharmanutra S.p.A. Between January 1995 and April 1996, Mr. Lacorte carried out military service with the Marines. Betwe...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & President | no data | €2.19m | no data | |
| Vice Chairman | no data | €1.92m | 0.15% € 755.2k | |
| Delegate Advisor | no data | €1.77m | 10.58% € 54.7m | |
| Scientific Director & Executive Director | 13.8yrs | €586.16k | no data | |
| Independent Director | no data | €41.00k | no data | |
| Lead Independent Director | no data | €41.00k | no data | |
| Independent Director | no data | €41.00k | no data | |
| Standing Auditor | no data | no data | no data | |
| President of Supervisory Board | 1.8yrs | no data | no data | |
| Internal Member of Supervisory Board | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
56yo
Average Age
Experienced Board: PHN's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.